ImaRx Commences SonoLysis Phase I/II Clinical Trials for Unique Vascular Blood Clot Treatment
28. September 2004 13:00 ET
|
ImaRx Therapeutics, Inc.
TUCSON, Ariz., Sept. 28, 2004 (PRIMEZONE) -- ImaRx Therapeutics, Inc., (www.imarx.com) announces the initiation of its Phase I/II clinical trials in deep vein thrombosis. The study is designed to...
ImaRx Presenting SonoLysis Technology at Two Major Conferences Using Microbubbles and Ultrasound to Dissolve Blood Clots
09. September 2004 13:41 ET
|
ImaRx Therapeutics, Inc.
TUCSON, Ariz., Sept. 9, 2004 (PRIMEZONE) -- ImaRx Therapeutics, Inc. (www.imarx.com) is pleased to announce that two of its employees will be giving invited talks at scientific meetings during...